Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2084 | 4777 | 32.6 | 59% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
75 | 80922 | MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1472 | 2549 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE//O 6 BENZYLGUANINE//ALKYLTRANSFERASE |
13846 | 745 | SARCNU//TAUROMUSTINE//S 2250 KAWAGISHI |
16247 | 598 | BIS TRIAZENE//TRIAZENE//BISTRIAZENE |
19491 | 438 | MTIC//DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL//VLAK PROTOCOL |
23525 | 288 | VNP40101M//CLORETAZINE//NEW ANTICANCER AGENT |
28988 | 159 | TRIMELAMOL//HEXAMETHYLMELAMINE//DEHYDROEMETINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | Author keyword | 140 | 86% | 1% | 70 |
2 | ALKYLTRANSFERASE | Author keyword | 102 | 86% | 1% | 51 |
3 | O 6 BENZYLGUANINE | Author keyword | 93 | 80% | 1% | 57 |
4 | O 6 METHYLGUANINE DNA METHYLTRANSFERASE | Author keyword | 81 | 55% | 2% | 102 |
5 | O 6 METHYLGUANINE | Author keyword | 50 | 61% | 1% | 54 |
6 | MGMT | Author keyword | 39 | 24% | 3% | 140 |
7 | LOMEGUATRIB | Author keyword | 34 | 93% | 0% | 13 |
8 | CANC UK CARCINOGENESIS GRP | Address | 31 | 61% | 1% | 33 |
9 | BIS TRIAZENE | Author keyword | 30 | 100% | 0% | 12 |
10 | O 6 ALKYLGUANINE | Author keyword | 27 | 92% | 0% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 140 | 86% | 1% | 70 | Search O+6+ALKYLGUANINE+DNA+ALKYLTRANSFERASE | Search O+6+ALKYLGUANINE+DNA+ALKYLTRANSFERASE |
2 | ALKYLTRANSFERASE | 102 | 86% | 1% | 51 | Search ALKYLTRANSFERASE | Search ALKYLTRANSFERASE |
3 | O 6 BENZYLGUANINE | 93 | 80% | 1% | 57 | Search O+6+BENZYLGUANINE | Search O+6+BENZYLGUANINE |
4 | O 6 METHYLGUANINE DNA METHYLTRANSFERASE | 81 | 55% | 2% | 102 | Search O+6+METHYLGUANINE+DNA+METHYLTRANSFERASE | Search O+6+METHYLGUANINE+DNA+METHYLTRANSFERASE |
5 | O 6 METHYLGUANINE | 50 | 61% | 1% | 54 | Search O+6+METHYLGUANINE | Search O+6+METHYLGUANINE |
6 | MGMT | 39 | 24% | 3% | 140 | Search MGMT | Search MGMT |
7 | LOMEGUATRIB | 34 | 93% | 0% | 13 | Search LOMEGUATRIB | Search LOMEGUATRIB |
8 | BIS TRIAZENE | 30 | 100% | 0% | 12 | Search BIS+TRIAZENE | Search BIS+TRIAZENE |
9 | O 6 ALKYLGUANINE | 27 | 92% | 0% | 11 | Search O+6+ALKYLGUANINE | Search O+6+ALKYLGUANINE |
10 | TRIAZENE | 27 | 44% | 1% | 47 | Search TRIAZENE | Search TRIAZENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 360 | 57% | 9% | 429 |
2 | O6 METHYLGUANINE DNA METHYLTRANSFERASE | 329 | 79% | 4% | 208 |
3 | O6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 236 | 88% | 2% | 113 |
4 | O6 BENZYLGUANINE | 202 | 93% | 2% | 77 |
5 | ALKYLATING AGENTS | 197 | 28% | 12% | 588 |
6 | HUMAN O6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 131 | 79% | 2% | 85 |
7 | O 6 METHYLGUANINE DNA METHYLTRANSFERASE | 121 | 36% | 6% | 268 |
8 | HUMAN O6 METHYLGUANINE DNA METHYLTRANSFERASE | 117 | 93% | 1% | 43 |
9 | HUMAN O 6 METHYLGUANINE DNA METHYLTRANSFERASE | 104 | 84% | 1% | 57 |
10 | HUMAN O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 102 | 73% | 2% | 78 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MGMT: Its role in cancer aetiology and cancer therapeutics | 2004 | 363 | 118 | 82% |
MAMMALIAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE - REGULATION AND IMPORTANCE IN RESPONSE TO ALKYLATING CARCINOGENIC AND THERAPEUTIC AGENTS | 1990 | 736 | 161 | 94% |
STRUCTURE, FUNCTION, AND INHIBITION OF O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | 1995 | 344 | 247 | 89% |
Repair of O-6-alkylguanine by alkyltransferases | 2000 | 351 | 135 | 86% |
Balancing repair and tolerance of DNA damage caused by alkylating agents | 2012 | 103 | 196 | 33% |
Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials | 1997 | 382 | 78 | 76% |
MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents | 2007 | 207 | 197 | 58% |
Clinical relevance of MGMT in the treatment of cancer | 2002 | 241 | 94 | 81% |
Multifaceted Roles of Alkyltransferase and Related Proteins in DNA Repair, DNA Damage, Resistance to Chemotherapy, and Research Tools | 2011 | 42 | 249 | 67% |
O-6-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistry | 2011 | 43 | 166 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC UK CARCINOGENESIS GRP | 31 | 61% | 0.7% | 33 |
2 | S 2250 KAWAGISHI | 8 | 100% | 0.1% | 5 |
3 | DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL | 8 | 23% | 0.6% | 29 |
4 | PL TOXICOL | 7 | 20% | 0.6% | 29 |
5 | MED BIOREGULAT BIOCHEM | 6 | 100% | 0.1% | 4 |
6 | SECT GENOME DAMAGE REPAIR | 5 | 32% | 0.3% | 12 |
7 | SEZ CHIM FARMACEUT BIOL | 4 | 40% | 0.2% | 8 |
8 | CRC SECT GENOME DAMAGE REPAIR | 3 | 57% | 0.1% | 4 |
9 | MOL CELL BIOL CHEM CARCINOGENESIS | 3 | 100% | 0.1% | 3 |
10 | PATERSON CANC CARCINOGENESIS | 3 | 100% | 0.1% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000021651 | N NITROSAMINES//NDMA//N NITROSODIMETHYLAMINE NDMA |
2 | 0.0000011787 | XERODERMA PIGMENTOSUM//COCKAYNE SYNDROME//NUCLEOTIDE EXCISION REPAIR |
3 | 0.0000011639 | BASE EXCISION REPAIR//DNA GLYCOSYLASE//URACIL DNA GLYCOSYLASE |
4 | 0.0000009454 | MUTATION RESEARCH//MUTAGENESIS//MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS |
5 | 0.0000008758 | TRANSLESION SYNTHESIS//DNA POLYMERASE//RECA PROTEIN |
6 | 0.0000008293 | EPENDYMOMA//MEDULLOBLASTOMA//GLIOBLASTOMA |
7 | 0.0000007075 | BLOOD BRAIN BARRIER//SUICIDE TRANSPORT//INTRACAROTID CHEMOTHERAPY |
8 | 0.0000007033 | 1 HYDROXYPYRENE//POLYCYCLIC AROMATIC HYDROCARBONS//DNA ADDUCTS |
9 | 0.0000006857 | CONVECTION ENHANCED DELIVERY//GLIADEL//CARMUSTINE WAFERS |
10 | 0.0000006757 | METHYLAZOXYMETHANOL//MICRENCEPHALY//EMBRYOL TERATOL |